Abstract:Abstract Background Interferon α (IFNα) is a cytokine whose production is increased endogenously in response to viral infection and in autoimmune diseases such as systemic lupus erythematosus (SLE). An elevated IFNα signature has been associated with clinically observed neuro-behavioural deficits such as mild cognitive impairment, fatigue, depression and psychosis in these diseases. However, the mechanisms underlying these neuropsychiatric symptoms remain largely unknown, and it is as yet unclear how IFNα signalling might influence central nervous system (CNS) function. Aberrant microglia-mediated synaptic pruning and function has recently been implicated in several neurodegenerative and neuropsychiatric diseases, but whether and how IFNα modulates these functions are not well defined. Methods Using a model of peripheral IFNα administration, we investigated gene expression changes due to IFNAR signalling in microglia. Bulk RNA sequencing on sorted microglia from wild type and microglia-specific Ifnar1 conditional knockout mice was performed to evaluate IFNα and IFNAR signalling-dependent changes in gene expression. Furthermore, the effects of IFNα on microglia morphology and synapse engulfment were assessed, via immunohistochemistry and flow cytometry. Results We found that IFNα exposure through the periphery induces a unique gene signature in microglia that includes the expected upregulation of multiple interferon-stimulated genes (ISGs), as well as the complement component C4b . We additionally characterized several IFNα-dependent changes in microglial phenotype, including expression of CD45 and CD68, cellular morphology and presynaptic engulfment, that reveal subtle brain region-specific differences. Finally, by specifically knocking down expression of IFNAR1 on microglia, we show that these changes are largely attributable to direct IFNAR signalling on microglia and not from indirect signalling effects through other CNS parenchymal cell types which are capable of IFNα-IFNAR signal transduction. Conclusions Peripheral IFNα induces unique genetic and phenotypic changes in microglia that are largely dependent on direct signalling through microglial IFNAR. The IFNα-induced upregulation of C4b could play important roles in the context of aberrant synaptic pruning in neuropsychiatric disease.

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease

The NLRP3 Inflammasome is Involved in Resident Intruder Paradigm-Induced Aggressive Behaviors in Mice

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

Interferon Regulatory Factor 5 Regulates the Phagocytosis of Microglia and Alleviate Alzheimer's Pathology.

Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer’s Disease

Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease

IRF3 inhibits inflammatory signaling pathways in macrophages to prevent viral pathogenesis

IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation

The PHD3-FOXO3 axis modulates the interferon type I response in microglia aggravating Alzheimer's disease progression

The role of interferon signaling in neurodegeneration and neuropsychiatric disorders

Targeting NLRP3 inflammasome for neurodegenerative disorders

Microglial responses to peripheral type 1 interferon

RND3 Modulates Microglial Polarization and Alleviates Neuroinflammation in Parkinson’s Disease by Suppressing NLRP3 Inflammasome Activation

The role of ZC3H12D-regulated TLR4-NF-κB pathway in LPS-induced pro-inflammatory microglial activation

TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer's Disease

IRF3-binding lncRNA-ISIR strengthens interferon production in viral infection and autoinflammation

NLRC3 Delays the Progression of AD in APP/PS1 Mice Via Inhibiting PI3K Activation

RND3 modulates microglial polarization and alleviates neuroinflammation in Parkinson's disease by suppressing NLRP3 inflammasome activation

Reduced SH3RF3 may protect against Alzheimer disease by lowering microglial pro-inflammatory responses via modulation of JNK and NFkB signaling

SDS3 Regulates Microglial Inflammation by Modulating the Expression of the Upstream Kinase ASK1 in the P38 MAPK Signaling Pathway.